Previous close | 4.5000 |
Open | N/A |
Bid | 4.5000 |
Ask | 9.5000 |
Strike | 62.50 |
Expiry date | 2026-01-16 |
Day's range | 4.5000 - 4.5000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats
Catalent (CTLT) delivered earnings and revenue surprises of -125% and 3.10%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?